![Jan McCoy Hutchinson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan McCoy Hutchinson
Keine laufenden Positionen mehr
Karriereverlauf von Jan McCoy Hutchinson
Ehemalige bekannte Positionen von Jan McCoy Hutchinson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RCT BioVentures
![]() RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Corporate Officer/Principal | 01.01.1991 | 30.03.2010 |
Sertoli Technologies LLC
![]() Sertoli Technologies LLC Medical/Nursing ServicesHealth Services Sertoli Technologies, Inc. provides medical services. It develops products to treat insulin-dependent diabetes and hemophilia. The company technology enables treatment of life-threatening diseases caused by a patient's impaired ability to produce a protein, such as insulin in diabetes or factor XIII in hemophilia. Sertoli Technologies was founded in 1996 and is headquartered in Tucson, AZ. | Corporate Officer/Principal | - | - |
Ausbildung von Jan McCoy Hutchinson
University of Arizona | Graduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Finance | 2 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
RCT BioVentures
![]() RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Finance |
Sertoli Technologies LLC
![]() Sertoli Technologies LLC Medical/Nursing ServicesHealth Services Sertoli Technologies, Inc. provides medical services. It develops products to treat insulin-dependent diabetes and hemophilia. The company technology enables treatment of life-threatening diseases caused by a patient's impaired ability to produce a protein, such as insulin in diabetes or factor XIII in hemophilia. Sertoli Technologies was founded in 1996 and is headquartered in Tucson, AZ. | Health Services |
- Börse
- Insiders
- Jan McCoy Hutchinson
- Erfahrung